We have moved to new location, Please click on contact us  
Home  >  News
you can get e-magazine links on WhatsApp. Click here
  EMA validates MAA for Henlius' Hansizhuang in combo with chemotherapy to treat adults with extensive-stage small cell lung cancer,   March 25, 2023
  Lupin’s partner Caplin receives US FDA approval for rocuronium bromide injection,   March 20, 2023
  Relief Therapeutics provides update from collaboration partner, ACER Therapeutics on commercial launch activities for Olpruva,   March 16, 2023
  Endo introduces generic Pylera capsules in US markets,   March 13, 2023
  Alnylam Pharma, Medison expand collaboration to a multi-regional partnership to commercialize RNAi therapeutics,   March 10, 2023
  CB Scientific enters Canadian distribution agreement with Your Heart Protector Corp,   March 10, 2023
  Glenmark, Cediprof enter supply and distribution agreement for US FDA approved generic version of Adderall tablets in US markets,   March 09, 2023
  Bactiguard collaborates with Quintess Medical to launch wound care products in UK & Ireland,   March 06, 2023
  Apotex issues voluntary recall of brimonidine tartrate ophthalmic solution, 0.15% due to cracks that have developed in some of units caps of bottles,   March 04, 2023
  Santhera seeks UK MHRA marketing approval for for vamorolone to treat Duchenne muscular dystrophy,   March 03, 2023
  Nubeqa receives European marketing approval for additional indication in prostate cancer,   March 03, 2023
  US FDA accepts Bristol Myers Squibb’s sBLA & EMA validates application for Opdivo,   March 02, 2023
  Bayer seeks Japanese marketing approval for aflibercept 8 mg to treat nAMD and diabetic macular edema,   March 02, 2023
  Enzene Biosciences begins commercial supply of biosimilar adalimumab in India to treat AS & RA,   February 28, 2023
  EMA committee recommends refusal of marketing authorization for Merck & Ridgeback’s Lagevrio to treat certain adults who have been diagnosed with Covid-19,   February 27, 2023
  ViiV Healthcare gets European marketing authorisation for Triumeq PD to treat children living with HIV,   February 24, 2023
  UK MHRA grants full marketing authorization to Karyopharm, Menarini Group’s Nexpovio in combo with bortezomib & dexamethasone to treat MM who have received at least one prior therapy,   February 22, 2023
  Venus Remedies gets marketing approval for cancer drugs from Uzbekistan, Palestine,   February 22, 2023
  UK MHRA accepts Shanghai Junshi Biosciences’ marketing authorization application for toripalimab,   February 22, 2023
  European Commission grants conditional marketing authorization to CSL’s gene therapy, Hemgenix for haemophilia B,   February 22, 2023

India Lab Expo
Copyright © 2016 Saffron Media Pvt. Ltd |